Natixis’s Covetrus, Inc. Common Stock CVET Stock Holding History

Natixis’s Portfolio CVET Stock Details CVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-95,811	Closed	-$2.34M	–	952
2019 Q2	$2.34M	Buy	+95,811	New	+$2.76M	0.02%	421

Other funds holding CVET

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CDR

Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Natixis's CVET Position: Q3 2019 in Review

Natixis sold out of Covetrus, Inc. Common Stock (CVET) in Q3 2019, closing a stake of 95,811 shares — an estimated $2.34M sold.

Natixis first reported a position in CVET in Q2 2019 and held it in 1 quarter. The position peaked at $2.34M in Q2 2019. 282 funds tracked by Wall St. Rank hold CVET as of Q3 2019.

Natixis reported no remaining Covetrus, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
Natixis sold 95,811 Covetrus, Inc. Common Stock shares in Q3 2019, an estimated $2.34M.
Natixis first reported a position in Covetrus, Inc. Common Stock in Q2 2019 and held it in 1 quarter.
Natixis's Covetrus, Inc. Common Stock position peaked at $2.34M in Q2 2019.
282 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q3 2019.

Based on Natixis's 13F filing for Q3 2019, filed 13 Nov 2019.